PROVIDER PROFILE · NPI 1306105309

Michael ChengMD

Hematology-OncologySan Francisco, CAI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

244

Unique beneficiaries

—

Total services

735

Distinct HCPCS

Medicare payment

$50K

Peer benchmark

Total Medicare services vs. 957 Hematology-Oncology providers in CA — below median (cohort median 4,173).

PRESCRIBING · PART D · 2024

Total Rx claims

128

Beneficiaries

—

Total drug cost

$2.0M

Distinct drugs

Brand share

82.0%

Top prescribed drugs

Osimertinib Mesylate70 claims

Alectinib Hcl24 claims

Prochlorperazine Maleate12 claims

Ondansetron Hcl11 claims

Tepotinib Hcl11 claims

QUALITY · MIPS · 2024

Final MIPS score

84.9

Quality

81.1

Cost

71.5

Improvement activities

40.0

Promoting interop.

0.0

Payment adjustment

0.42%

Group

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$2K

Payment records

By payment type

Travel and Lodging$1K

Food and Beverage$546

FACILITY AFFILIATIONS

Hospital & Facility Affiliations (1)

CCN 050454

Hospital

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history